Body Mass Index and Survival in Esophageal Adenocarcinoma Treated with Chemoradiotherapy Followed by Esophagectomy
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Body mass index (BMI) has been linked with inferior outcomes in gastrointestinal malignancies. The purpose of this study is to evaluate the effect of BMI on survival in patients with esophageal adenocarcinoma.
Medical records were analyzed for patients who underwent esophagectomy after neoadjuvant chemoradiotherapy (nCRT) for adenocarcinoma from 2000 to the present. Patients were grouped into BMI ≤25, >25–30, >30–35, and BMI >35. Overall survival (OS) and disease-free survival (DFS) were analyzed using the Kaplan–Meier method. Multivariate analysis (MVA) was performed using Cox proportional hazard regression model.
We identified 303 patients for the analysis. The only difference in patient characteristics between groups was gender. We found no difference in OS and DFS associated with BMI (p = 0.3297 for OS; p = 0.5950 for DFS). There were no differences in postoperative complications or mortality between BMI groups. MVA revealed that higher stage and less than a complete response to nCRT were prognostic for worse OS and DFS, while age, gender, type of surgery, year of diagnosis, and BMI were not prognostic.
BMI was neither associated with surgical complications nor survival in patients with esophageal adenocarcinoma treated with nCRT. BMI should not be considered a contraindication to surgical resection after nCRT.
- Cancer Statistics, in Clinical Cancer Advances 20092009, American Society of Clinical Oncology: Alexandria, VA.
- Lambert, R. and P. Hainaut, Esophageal cancer: cases and causes (part I). Endoscopy, 2007. 39(6): p. 550-5. CrossRef
- Blot, W.J. and J.K. McLaughlin, The changing epidemiology of esophageal cancer. Semin Oncol, 1999. 26(5 Suppl 15): p. 2-8.
- Brown, L.M., S.S. Devesa, and W.H. Chow, Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst, 2008. 100(16): p. 1184-7. CrossRef
- Renehan, A.G., et al., Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet, 2008. 371(9612): p. 569-78. CrossRef
- Chak, A., et al., Assessment of familiality, obesity, and other risk factors for early age of cancer diagnosis in adenocarcinomas of the esophagus and gastroesophageal junction. Am J Gastroenterol, 2009. 104(8): p. 1913-21. CrossRef
- Carmichael, A.R., Obesity and prognosis of breast cancer. Obes Rev, 2006. 7(4): p. 333-40. CrossRef
- Chlebowski, R.T., E. Aiello, and A. McTiernan, Weight loss in breast cancer patient management. J Clin Oncol, 2002. 20(4): p. 1128-43. CrossRef
- Dignam, J.J., et al., Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst, 2006. 98(22): p. 1647-54. CrossRef
- Li, D., et al., Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA, 2009. 301(24): p. 2553-62. CrossRef
- Chow, W.H., et al., Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst, 1998. 90(2): p. 150-5. CrossRef
- El-Serag, H.B., et al., Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol, 2005. 100(10): p. 2151-6. CrossRef
- Lagergren, J., R. Bergstrom, and O. Nyren, Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med, 1999. 130(11): p. 883-90.
- Shaheen, N. and D.F. Ransohoff, Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: scientific review. Jama, 2002. 287(15): p. 1972-81. CrossRef
- Murray, L., et al., Relationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter Project. Int J Epidemiol, 2003. 32(4): p. 645-50. CrossRef
- Nilsson, M., et al., Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. Jama, 2003. 290(1): p. 66-72. CrossRef
- Calle, E.E., et al., Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med, 2003. 348(17): p. 1625-38. CrossRef
- Enzinger, P.C. and R.J. Mayer, Esophageal cancer. N Engl J Med, 2003. 349(23): p. 2241-52. CrossRef
- Vaughan, T.L., et al., Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev, 1995. 4(2): p. 85-92.
- Moon, H.G., et al., Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol, 2008. 15(7): p. 1918-22. CrossRef
- Stewart, S.T., D.M. Cutler, and A.B. Rosen, Forecasting the effects of obesity and smoking on U.S. life expectancy. N Engl J Med, 2009. 361(23): p. 2252-60. CrossRef
- Dindo, D., et al., Obesity in general elective surgery. Lancet, 2003. 361(9374): p. 2032-5. CrossRef
- Melis, M., et al., An elevated body mass index does not reduce survival after esophagectomy for cancer. Annals of surgical oncology, 2011. 18(3): p. 824-31. CrossRef
- Grotenhuis, B.A., et al., Prognostic Value of Body Mass Index on Short-Term and Long-Term Outcome after Resection of Esophageal Cancer. World J Surg, 2010.
- Kilic, A., et al., Impact of obesity on perioperative outcomes of minimally invasive esophagectomy. Ann Thorac Surg, 2009. 87(2): p. 412-5. CrossRef
- Healy, L.A., et al., Impact of obesity on outcomes in the management of localized adenocarcinoma of the esophagus and esophagogastric junction. J Thorac Cardiovasc Surg, 2007. 134(5): p. 1284-91. CrossRef
- Morgan, M.A., et al., Prognostic significance of body mass indices for patients undergoing esophagectomy for cancer. Dis Esophagus, 2007. 20(1): p. 29-35. CrossRef
- Rodriguez, C., et al., Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev, 2001. 10(4): p. 345-53.
- Rodriguez, C., et al., Effect of body mass on the association between estrogen replacement therapy and mortality among elderly US women. Am J Epidemiol, 2001. 153(2): p. 145-52. CrossRef
- McRackan, T.R., et al., Effect of body mass index on chemoradiation outcomes in head and neck cancer. Laryngoscope, 2008. 118(7): p. 1180-5. CrossRef
- Body Mass Index and Survival in Esophageal Adenocarcinoma Treated with Chemoradiotherapy Followed by Esophagectomy
Journal of Gastrointestinal Surgery
Volume 16, Issue 7 , pp 1296-1302
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Body mass index
- Esophageal adenocarcinoma
- Neoadjuvant chemoradiotherapy
- Industry Sectors
- Author Affiliations
- 1. Department of Radiation Oncology, H. Lee Moffitt Cancer Center, 12902 Magnolia Dr., Tampa, FL, 33612, USA
- 4. H. Lee Moffitt Cancer Center, Tampa, FL, USA
- 2. School of Medicine, University of South Florida, Tampa, FL, USA
- 3. Gastrointestinal Tumor Program, H. Lee Moffitt Cancer Center, Tampa, FL, USA